CytoDyn (CYDY) Tax Rate (2018 - 2026)
CytoDyn's (CYDY) quarterly Tax Rate came in at 0.0% in Q2 2019, down 100.0% on a QoQ basis from 16.5% in Q4 2018.
Powered by 
Analysis
CytoDyn (CYDY) Tax Rate (2018 - 2026) Analysis & Trends
CytoDyn (CYDY) has 2 years of Tax Rate data on file, last reported at 0.0% in Q2 2019.
- Quarterly Tax Rate changed N/A year-over-year to 0.0% in Q2 2019, while the trailing twelve-month figure through Feb 2020 was 0.0% (down 526.0% YoY) and the FY2019 annual result came in at 4.45%, changed N/A from the prior year.
- Tax Rate eased to 0.0% in Q2 2019, from 16.5% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 16.5% in Q4 2018 to a low of 0.0% in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.32 Bn | 131.47 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.53 Bn | 77.54 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 57.64 Bn | 52.50 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.21 Bn | 31.90 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.34 Bn | 26.17 Bn | 358.27 Mn | -16.71% |
| 10 | CytoDyn | 259.28 Mn | 259.28 Mn | - | 90.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 90.92% |
| May 31, 2019 | 0.00% |
| Nov 30, 2018 | 16.50% |